Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1988-04-21
1990-12-04
Schwartz, Richard A.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
536 27, 435320, 4351723, 4352401, 935 70, 935 71, 935 41, 530387, C12N 510, C12N 100, C12N 1500
Patent
active
049753690
ABSTRACT:
The present invention comprises novel recombinant DNA compounds which encode monoclonal antibody KS1/4 and chimeric derivatives of monoclonal antibody KS1/4. Eukaryotic expression vectors have been constructed that comprise novel KS1/4-encoding DNA and drive expression of KS1/4 when transformed into an appropriate host cell. The novel expression vectors can be used to create modified and chimeric derivatives of KS1/4. The recombinant-produced KS1/4, KS1/4 derivatives and KS1/4 chimeras are useful for the diagnosis, prognosis and treatment of disease states including adenocarcinoma.
REFERENCES:
patent: 4816567 (1989-03-01), Cabily
Shaw, D. R. et al, Jun. 15, 1987, J. Immunol. 138(12), 4534-4538.
Sikorav J-L. et al, 1980, Nucleic Acids Res., 8(14), 3143-3155.
Hamyn, P. H. et al., 1981, Nucleic Acids Res., 9, 4485-4494.
Yamawaki-Kataoka, Y., et al, 1987, Nucleic Acids Res. 9(6), 1365-1381.
Neuberger et al., 1984, Nature, 312:604-608.
Caton, A. J., 1986, Hybridoma, 5:511-516.
Bumol et al., in Ceriani, R. L. ed., Immunological Approaches to the Diagnosis and Therapy of Breast Cancer.
Varki et al., 1984, Cancer Research, 44:681-687.
Spearman et al., 1987, J. Pharmacol. and Exp. Therapeutics, 241:695-703.
Sahagan et al., 1986, J. Immunol., 21:1066-1074.
EP 0171496, 2/19/86, European Patent.
Sun et al., 1986, Hybridoma, 5: 517-520.
WO 87/02671, 5/7/87, PCT.
Sun et al., 1987, PNAS, 84:214-218.
Liu et al., 1987, PNAS, 84:3439-3443.
Bumol, T. F. in Reisfeld, R. A. and Sells, S. eds., Monoclonal Antibodies and Cancer Therapy.
Morrison et al., 1986, The Mount Sinai J. of Med., 53:175-180.
Oi et al., 1983, PNAS, 80:825-829.
Grinnell et al., 1986, Molecular and Cellular Biology, 6:3596-3605.
Boullianne et al., 1984, Nature, 312:643-646.
Beavers Lisa S.
Bumol Thomas F.
Gadski Robert A.
Weigel Barbara J.
Eli Lilly and Company
Marks Michelle S.
Norman Douglas K.
Schwartz Richard A.
Whitaker Leroy
LandOfFree
Recombinant and chimeric KS1/4 antibodies directed against a hum does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant and chimeric KS1/4 antibodies directed against a hum, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant and chimeric KS1/4 antibodies directed against a hum will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-883091